Handelsbanken Fonder Ab Bausch Health Companies Inc. Transaction History

Handelsbanken Fonder Ab

$24.3 Billion
Q1 2025

A detailed history of Handelsbanken Fonder Ab transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 65,100 shares of BHC stock, worth $332,010. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,100

Previous 65,100 -0.0%

Holding current value

$332,010

Previous $525,000 19.81%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$7.34 - $9.78 $74,134 - $98,778	10,100 Added 18.36%	65,100 $525,000
Q2 2024 Aug 05, 2024	SELL	$6.1 - $10.41 $24,400 - $41,640	-4,000 Reduced 6.78%	55,000 $383,000
Q2 2023 Aug 02, 2023	SELL	$5.72 - $8.8 $126,412 - $194,480	-22,100 Reduced 27.25%	59,000 $472,000
Q4 2022 Feb 07, 2023	BUY	$6.09 - $7.93 $233,247 - $303,719	38,300 Added 89.49%	81,100 $509,000
Q2 2022 Aug 03, 2022	SELL	$7.06 - $23.63 $33,182 - $111,061	-4,700 Reduced 9.89%	42,800 $358,000
Q1 2022 May 11, 2022	SELL	$21.6 - $27.79 $144,720 - $186,193	-6,700 Reduced 12.36%	47,500 $1.09 Million
Q3 2021 Nov 10, 2021	BUY	$25.04 - $30.06 $27,544 - $33,066	1,100 Added 2.07%	54,200 $1.51 Million
Q2 2021 Aug 03, 2021	SELL	$27.43 - $32.7 $153,608 - $183,120	-5,600 Reduced 9.54%	53,100 $1.56 Million
Q1 2021 Apr 29, 2021	SELL	$21.37 - $34.38 $220,111 - $354,114	-10,300 Reduced 14.93%	58,700 $1.86 Million
Q4 2020 Feb 11, 2021	BUY	$15.31 - $21.12 $128,604 - $177,408	8,400 Added 13.86%	69,000 $1.44 Million
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $806,586 - $1.24 Million	60,600 New	60,600 $1.11 Million

Others Institutions Holding BHC

# of Institutions

273

Shares Held

252M

Call Options Held

5.12M

Put Options Held

9.43M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $1.84B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Bausch Health Companies Inc. Transaction History